| Issue Type | Login |
|---|---|
| Country | Germany |
| Industry | Login |
| Region | Login |
| Maturity Date | 2029-02-20 |
| Par Value | 100000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 650.00 |
| Coupon | 2.5 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 650.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Novo Nordisk Finance (Netherlands) B.V. corporate medium term notes has a 2.50% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 650.00 million EUR and matures on February 20, 2029 with a last coupon date of FEB 28, 2020. |
Novo Nordisk Finance (Netherlands) B.V., founded in 1999 and based in Amsterdam, serves as the financing arm of Novo Nordisk A/S, a global leader in diabetes care and hormone replacement therapies. The company primarily focuses on providing financial support to its parent company's operations while managing a diverse portfolio of funding instruments.